Hepatitis
B Top News Articles
|
|
|
 Executive
Summary Now Available from Hepatitis B and C National Expert
Policy Forum
10-20-2009
|
 Long-term
Studies Show Tenofovir (Viread)
Safety and Efficacy Is Sustained at 3 Years in HBeAg Positive
and Negative Hepatitis B Patients
11-3-2009
|
Entecavir
(Baraclude) Demonstrates Greater Antiviral Activity
than Adefovir (Hepsera)
in Hepatitis B Patients with Decompensated Liver Disease
11-3-2009
|
AASLD
Liver Meeting Starts Today
in Boston
10-30-2009
|
 Hepatitis
B Virus Genotypes E, F, G, and H Appear Responsive to Treatment
with Interferon Alpha
10-13-2009
|
Most
Patients with Low Baseline HBV Viral Load Can Safely Discontinue
Lamivudine (Epivir-HBV)
after Achieving Virological Suppression
10-09-2009
|
 Widespread
Hepatitis B Vaccination
Has Dramatically Reduced Rate of Liver Cancer among Children
and Young Adults in Taiwan
9-29-2009
|
AASLD
Issues Updated Practice Guidelines for Management of Chronic
Hepatitis B
9-22-2009
|
Sustained
Response in HBeAg Negative Chronic Hepatitis B Patients 3 Years
After Treatment with Pegasys
8-18-2009
|
 FDA
Changes Regulations for Expanded Access
to Investigational Drugs
8-14-2009 |
Predictors
of Good Response to Telbivudine (Tyzeka)
for Chronic Hepatitis B
8-4-2009
|
Vertex
Aims to Receive $250 Million in Milestone Payments for Anti-HCV
Drug Telaprevir after Approval in Europe
7-14-2009
|
 CDC
Researchers Release Latest Hepatitis
A, B, and C Statistics
6-23-2009
|
 Many
People with Chronic Hepatitis B
and C Do Not Receive Appropriate Treatment
6-16-2009
|
High
HBV DNA Level Is the Strongest Predictor of Elevated
ALT
6-9-2009
|
Should
Entecavir (Baraclude) and
Tenofovir (Viread) Be First-line
Treatment for Chronic Hepatitis B?
6-5-2009 |
Slides
and Posters on Entecavir (Baraclude)
and Hepatitis B Liver Disease Progression Presented at DDW 2009
6-5-2009 |
 Factors
Associated with Development of Hepatocellular
Carcinoma in Chronic Hepatitis B Patients
6-2-2009
|
Does
HBV Viral Load Level Predict
Development of Liver Fibrosis?
5-29-2009
|
 Study
Suggests Genetic Factors
May Help Explain High Rates of Hepatitis B among Asians
5/22/09 |
Researchers
Present Data on Investigational Cyclophilin Inhibitors Debio
025 and SCY-635
5/15/09
|
Telbivudine
(Tyzeka) Continues to Produce Good Results for Chronic
Hepatitis B Patients after 3 Years
5/08/09
|
Tenofovir
(Viread) Is Similarly Effective in Chronic Hepatitis
B Patients Regardless of Liver Cirrhosis Status
5/08/09
|
Addition
of Emtricitabine (Emtriva)
Does Not Improve Response to Tenofovir
(Viread) for Chronic Hepatitis B
5/05/09
|
Half
of HBeAg Negative Chronic Hepatitis B Patients Maintain Response
up to 5 Years after Stopping Long-term Adefovir
(Hepsera)
5/05/09
|
Chronic
Hepatitis B Patients Who Had Incomplete Response or Relapse
on Adefovir (Hepsera) Respond
Well to Entecavir (Baraclude)
5/01/09
|
Safety
and Efficacy of 96 Weeks of Tenofovir
(Viread) in Chronic Hepatitis B Patients Previously
Treated with Lamivudine (Epivir-HBV)
4/28/09
|
 Pharmasset
Halts Clinical Trials of Clevudine
for Chronic Hepatitis B Due to Safety Concerns, Will Focus on
Hepatitis C Pipeline
4/24/09
|
 Studies
of Hepatitis B and C Virus
Interaction Produce Conflicting Results
4/17/09
|
Some
Individuals Harbor HBV with Adefovir
(Hepsera) and Tenofovir (Viread) Resistance Mutations
before They Ever Receive Treatment
4/17/09
|
 Pegylated
Interferon Monotherapy for Treatment of Chronic Hepatitis
B
4/07/09
|
ImQuest
Identifies First Non-nucleoside Inhibitors
of Hepatitis B Virus
4/07/09
|
 Meta-analysis
Shows Interferon Reduces Progression to Cirrhosis
and Liver Cancer in People with Chronic Hepatitis
B
4/03/09
|
Chronic
Hepatitis B Patients May Need to Begin Liver
Cancer Screening at a Younger Age than Currently
Recommended
3/27/09
|
 Two
Year Tenofovir Disoproxil Fumarate
(TDF) Treatment and Adefovir Dipivoxil (ADV) Switch
Data in HBeAg-Positive Patients With Chronic Hepatitis B (Study
103)
3/27/09
|
 Variables
Impacting Treatment and Prognosis in Young Patients (under Age
40) who Develop Hepatitis B Virus-Associated
Hepatocellular Carcinoma; Implications for Management
of an Unscreened Population
3/27/09
|
Two
Year Tenofovir Disoproxil Fumarate
(TDF) Treatment and Adefovir Dipivoxil (ADV) Switch
Data in HBeAg-Negative Patients with Chronic Hepatitis B (Study
102)
3/27/09
|
Tenofovir
Disoproxil Fumarate (TDF) versus Adefovir Dipivoxil (ADV)
in Asians with HBeAg-Positive and HBeAg-Negative Chronic Hepatitis
B Participating in Studies 102 and 103
3/27/09 |
Many
Asian-American Primary Care Providers Do Not Screen their Asian-American
Patients Who Are at Risk for Chronic
Hepatitis B
3/24/09
|
Tenofovir
(Viread) during Pregnancy: Findings from the Antiretroviral
Pregnancy Registry
3/24/09
|
Frequent
Liver Function Tests Can Detect Transient ALT Increases
in Chronic Hepatitis B Patients
3/20/09 |
Entecavir (Baraclude)
Produces Greater Early HBV DNA Suppression than Adefovir (Hepsera)
in Chronic Hepatitis B Patients
3/17/09 |
Telbivudine
(Tyzeka) May Be Effective for Chronic Hepatitis B
Treatment after Failure of Adefovir (Hepsera)
3/10/09 |
 GLOBE
Trial 2-Year Data Shows Telbivudine
(Tyzeka) Is More Effective than Lamivudine
(Epivir-HBV) for Chronic Hepatitis B
2/27/2009 |
 HBV Relapse
after 48 Weeks of Entecavir (Baraclude)
Suggests Need for Continuous Therapy
2/24/2009 |
 Hepatitis
Delta Increases the Risk of Liver Cirrhosis and Hepatocellular
Carcinoma in People with Hepatitis
B
2/24/2009 |
 Does Telbivudine (Tyzeka)
Have Activity Against HIV?
2/17/2009 |
Despite
Infrequent "Blips," Tenofovir (Viread)
Provides Good Hepatitis B Virus Suppression HIV-HBV Coinfected
Individuals
2/17/2009 |
 Japanese Study Finds Entecavir
(Baraclude) Is Effective and Well-tolerated in Treatment-naive
Chronic Hepatitis B Patients
2/10/2009 |
 Monday Is Deadline to Apply for Association of Asian
Pacific Community Health Organizations Hepatitis
B Policy Fellowship
2/06/2009 |
European
Association for the Study of the Liver (EASL) Publishes First
Guidelines for Management of Chronic Hepatitis B
2/03/2009 |
Japanese
Study Finds Entecavir (Baraclude)
Is Effective and Well-tolerated in Treatment-naive Chronic Hepatitis
B Patients
2/03/2009 |
 Insulin
Resistance in Chronic Hepatitis B Patients Is Associated
with Other Metabolic Abnormalities, Not HBV Infection Itself
1/30/2009 |
CDC
Finds Failure to Follow Proper Infection-control
Procedures Put More than 60,000 People at Risk for
Hepatitis B and C over the
Past Decade
1/30/2009 |
 Adefovir (Hepsera)
Prevents Post-transplant HBV Recurrence as well as HBIG
1/27/2009 |
Final
Statement from Consensus
Development Conference on Management
of Hepatitis B
1/13/2009 |
Liver
Cirrhosis Is Common in HBeAg Negative Chronic Hepatitis
B Patients, especially Those with High ALT and HBV DNA Levels
1/23/2009
|
 Organizers
Announce 13th International Symposium
on Viral Hepatitis and Liver Disease, March 20-24
in Washington, DC
1/23/2009
|
Higher
Dose of Adefovir (Hepsera)
Are Not Effective for Chronic Hepatitis B Patients with Lamivudine
(Epivir) Resistance
1/09/2009 |
Significance
of HBV DNA Levels in People
with HBeAg Negative Chronic Hepatitis B
1/05/2009 |
|
 Perinatal
HBV Transmission and Management of Pregnant Women with Hepatitis
B
12/12/2008 |
 Do
HBeAg Negative Chronic Hepatitis B Patients with Low HBV Viral
Load Require Liver Biopsy?
12/08/2008 |
 Tenofovir
(Viread) versus Adefovir (Hepsera) for the Treatment of Chronic
Hepatitis B
12/05/2008 |
Baseline
CD4 Cell Count Predicts HBV DNA Decline in HIV Negative and
HIV Positive Patients Treated with Adefovir (Hepsera)
12/05/2008 |
